Published Online
on August 16, 2004

A more recent version of this article appeared on October 1, 2004

This Article Full Text (PDF) All Versions of this Article: 44/4/396    most recent 01.HYP.0000140925.73081.4cv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hao, C.-M. Articles by Breyer, M. D. Search for Related Content PubMed PubMed Citation Articles by Hao, C.-M. Articles by Breyer, M. D. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information High Blood Pressure Related Collections Other hypertension

Hypertension and Cyclooxygenase-2 Inhibitors. Target: The Renal Medulla

Chuan-Ming Hao^* and Matthew D. Breyer

From the Division of Nephrology, Department of Medicine, Vanderbilt University Medical School, Nashville, Tenn.

^* To whom correspondence should be addressed. E-mail: Chuanming.hao{at}vanderbilt.edu.

This article has been cited by other articles:

				J. I. Schwartz, C. Thach, K. C. Lasseter, J. Miller, D. Hreniuk, D. A. Hilliard, K. M. Snyder, B. J. Gertz, and K. M. Gottesdiener Effects of Etoricoxib and Comparator Nonsteroidal Anti-Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet J. Clin. Pharmacol., December 1, 2007; 47(12): 1521 - 1531. [Abstract] [Full Text] [PDF]

				W. B. White Cardiovascular Effects of the Cyclooxygenase Inhibitors Hypertension, March 1, 2007; 49(3): 408 - 418. [Full Text] [PDF]